Altogether, the above-mentioned studies provide evidence for the role of complement in cancer that seems to promote tumor progression by recruiting MDSCs to the tumor, reducing the infiltration of activated CD4+ T cells and stimulating new vessel formation. This evidence concerns the gene CD4 and neoplasm.